By employing a panel of cytokines reported to promote the “type 2” differentiation of PMN-MDSCs, we found that serum levels of Nodal, an embryonic morphogen involved in organ development and reactivated in aggressive melanoma and breast cancer [32,33], were significantly elevated in cancer patients. Here, NODAL is linked to breast carcinoma.